The vascular marker CD31 also highlights histiocytes and histiocyte-like cells within cutaneous tumors

36Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.

Abstract

Objectives: While useful in diagnosing angiosarcomas, CD31 can also highlight histiocytes within soft tissue tumors and lead to errors in diagnosis. We sought to determine how often CD31 highlights cutaneous histiocytomas and histiocytoma mimics. Methods: We examined eight epithelioid cell histiocytomas (ECHs), 12 xanthogranulomas (XGs), nine cases of Langerhans cell histiocytosis (LCH), eight reticulohistiocytomas, 11 xanthomas, 29 atypical fibroxanthomas, nine granular cell tumors, four cases of angiolymphoid hyperplasia with eosinophilia, nine intradermal Spitz nevi, and nine angiosarcomas with antibodies directed against CD31, CD34, CD163, and factor VIII. Results: CD31 marked cells in three of 12 XGs, four of nine cases of LCH, one of eight reticulohistiocytomas, one of 11 xanthomas, 10 of 29 atypical fibroxanthomas, four of four cases of angiolymphoid hyperplasia with eosinophilia, nine of nine angiosarcomas, zero of nine granular cell tumors, and zero of eight ECHs. CD34 and factor VIII were negative in all nonvascular cases. Conclusions: Our results indicate that CD31 can mark lesional cells and imitate vascular tumors in cutaneous histiocytomas and histiocytoma mimics, an error that can be avoided by using a panel of antibodies.

Cite

CITATION STYLE

APA

Vanchinathan, V., Mizramani, N., Kantipudi, R., Schwartz, E. J., & Sundram, U. N. (2015). The vascular marker CD31 also highlights histiocytes and histiocyte-like cells within cutaneous tumors. American Journal of Clinical Pathology, 143(2), 177–185. https://doi.org/10.1309/AJCPRHM8CZH5EMFD

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free